Navigation Links
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Date:9/27/2007

ith ST-segment elevation acute myocardial infarction, PLAVIX has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke. This benefit is not known to pertain to patients who receive primary angioplasty.

Important Risk Information

-- PLAVIX is contraindicated in patients with active pathologic bleeding

such as peptic ulcer or intracranial hemorrhage. PLAVIX should be used

with caution in patients who may be at risk of increased bleeding from

trauma, surgery, or coadministration with NSAIDs or warfarin. (See

CONTRAINDICATIONS and PRECAUTIONS.*)

-- The rates of major and minor bleeding were higher in patients treated

with PLAVIX plus aspirin compared with placebo plus aspirin in clinical

trials. (See ADVERSE REACTIONS.*)

-- As part of the worldwide post marketing experience with PLAVIX, there

have been cases of reported thrombotic thrombocytopenic purpura (TTP),

some with fatal outcome. TTP has been reported rarely following use of

PLAVIX, sometimes after a short exposure (<2 weeks). TTP is a serious

condition that can be fatal and requires urgent treatment including

plasmapheresis (plasma exchange). (See WARNINGS.*)

-- In clinical trials, the most common clinically important side effects

were pruritus, purpura, diarrhea, and rash; infrequent events included

intracranial hemorrhage (0.4%) and severe neutropenia (0.05%). (See

ADVERSE REACTIONS.*)

*Please see full prescribing information by visiting http://www.plavix.com.

About sanofi-aventis

Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiova
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Integration of the LEADseeker Multimodality Imaging System with automated plate loading and incubation using Overlord Instrument software
9. Marquette targets illegal downloading
10. Though VC investing is down, reloading on new funds is rising
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Axovant Sciences Ltd. (NYSE:  AXON), a leading ... announced upcoming presentations at three investor conferences: , ... Healthcare Conference in New York at ... at 2:00 PM at the BioCentury NewsMakers Conference in ... & Conference Center , Thursday, September 17 at 9:30 ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 /PRNewswire/ ... has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. ... the pharmaceutical and biotechnology industries is anticipated. ... of drug development - from formulations for ...
(Date:9/2/2015)... ARBOR, Mich. and LIBERTYVILLE, Ill. (PRWEB) , ... ... ... NSF International, a leading provider of regulatory compliance, quality systems, analytical ... Avarent LLC, a consulting firm with expertise in medical device products/processes development, ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... and Companies" to their offering. ... variations, development of sequencing technologies, and their applications. ... well as companies developing them. Various applications of ...
Breaking Biology Technology:Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2
... 2011 MiMedx Group, Inc.  (OTC Bulletin Board: ... of patent protected biomaterial-based products and bioimplants processed from ... year ended December 31, 2010. Full ... year to coincide with the calendar year. Its prior ...
... new tool to help diagnose symptomatic patients with Herpes Simplex ... sexually transmitted infections in the world.   BD ... today that it received U.S. Food and Drug Administration (FDA) ... detect and differentiate HSV types 1 and 2 in clinician-collected ...
... nuclear crisis has caused a surge in the demand ... but as far away as California, western Canada, and ... generalized radiation protection because it only shields the thyroid, ... the radiation hysteria mounts. A new and ...
Cached Biology Technology:MiMedx Group Announces 2010 Results 2MiMedx Group Announces 2010 Results 3MiMedx Group Announces 2010 Results 4MiMedx Group Announces 2010 Results 5MiMedx Group Announces 2010 Results 6MiMedx Group Announces 2010 Results 7BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens 2Shortages of Potassium Iodide as Radiation Panic Drives Demand 2
(Date:9/1/2015)... , Sept. 1, 2015  Automation and ... during airport passenger screening. This is the first ... screening process will become unintrusive. An assortment of ... on voluntary background investigations will transform the passenger ... & Sullivan, Global Airport Passenger Screening Market ...
(Date:8/28/2015)... August 28, 2015 According to ... Market by Assessment Type (Pen & Paper Based, Hosted, ... Corporate Learning, Academic Research), Vertical and Region - Global ... Training Market to grow from USD 2.4 Billion in ... Compound Annual Growth Rate (CAGR) of 25.6% from 2015 ...
(Date:8/24/2015)... TOWN, South Africa , August 24, 2015 ... Germany ,s largest biometrics manufacturer DERMALOG and ... with the "2015 African Biometrics Company of the Year ... in Nigeria .   -Cross ... and http://www.presseportal.de/nr/8896 - On Thursday evening, ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3
... faster thanks to a new technique incorporating quantum dots ... drug testing can take a decade or more, but ... have created an electronic quantum dots (Qdots) probe that ... to cancer cells. The research appears online in this ...
... University study has found that when people think about ... "Gender neutrality - a lack of preference - is ... developed countries like Canada," says Lonnie Aarssen, a Queen,s ... though, reveal a strong gender bias, despite the researchers, ...
... new German-based project is setting out to rescue biodiversity data ... in institutional databases, are kept in outdated digital storage systems, ... the Botanic Garden and Botanical Museum Berlin-Dahlem, provides a good ... biodiversity data. This is one of a set of ...
Cached Biology News:UCF nanotechnology may speed up drug testing 2German research team targets 'at risk' data on biodiversity 2German research team targets 'at risk' data on biodiversity 3
BD Primaria 35 mm Cell Culture Dish with Easy-Grip design, surface-modified polystyrene for enhanced cell culture. (20/sp, 200/ca) Packaging: 20 / sleeve, 500 / case ...
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
... a direct antibiotic-based selection system for recombinant ... survival, eliminating the need for costly color ... close to 100% accuracy in recombinant selection. ... robot colony picking. This cloning kit can ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~32 kDa DNase IIα chain and the ~40 kDa proenzyme. DNase II causes both DNA condensation and DNA fragmentation. ...
Biology Products: